High‐mobility group box 1 released by autophagic cancer‐associated fibroblasts maintains the stemness of luminal breast cancer cells
Cancer stem cells/cancer‐initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer‐associated fibroblasts (CAFs) are major components of the niche of breast cancer‐initiating cells (BCICs), and their interactions may profoundly...
Saved in:
Published in | The Journal of pathology Vol. 243; no. 3; pp. 376 - 389 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.11.2017
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cancer stem cells/cancer‐initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer‐associated fibroblasts (CAFs) are major components of the niche of breast cancer‐initiating cells (BCICs), and their interactions may profoundly affect breast cancer progression. Autophagy has been considered to be a critical process for CIC maintenance, but whether it is involved in the cross‐talk between CAFs and CICs to affect tumourigenesis and pathological significance has not been determined. In this study, we found that the presence of CAFs containing high levels of microtubule‐associated protein 1 light chain 3 (LC3II), a marker of autophagosomes, was associated with more aggressive luminal human breast cancer. CAFs in human luminal breast cancer tissues with high autophagy activity enriched BCICs with increased tumourigenicity. Mechanistically, autophagic CAFs released high‐mobility group box 1 (HMGB1), which activated its receptor, Toll‐like receptor (TLR) 4, expressed by luminal breast cancer cells, to enhance their stemness and tumourigenicity. Furthermore, immunohistochemistry of 180 luminal breast cancers revealed that high LC3II/TLR4 levels predicted an increased relapse rate and a poorer prognosis. Our findings demonstrate that autophagic CAFs play a critical role in promoting the progression of luminal breast cancer through an HMGB1–TLR4 axis, and that both autophagy in CAFs and TLR4 on breast cancer cells constitute potential therapeutic targets. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. |
---|---|
AbstractList | Cancer stem cells/cancer‐initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer‐associated fibroblasts (CAFs) are major components of the niche of breast cancer‐initiating cells (BCICs), and their interactions may profoundly affect breast cancer progression. Autophagy has been considered to be a critical process for CIC maintenance, but whether it is involved in the cross‐talk between CAFs and CICs to affect tumourigenesis and pathological significance has not been determined. In this study, we found that the presence of CAFs containing high levels of microtubule‐associated protein 1 light chain 3 (LC3II), a marker of autophagosomes, was associated with more aggressive luminal human breast cancer. CAFs in human luminal breast cancer tissues with high autophagy activity enriched BCICs with increased tumourigenicity. Mechanistically, autophagic CAFs released high‐mobility group box 1 (HMGB1), which activated its receptor, Toll‐like receptor (TLR) 4, expressed by luminal breast cancer cells, to enhance their stemness and tumourigenicity. Furthermore, immunohistochemistry of 180 luminal breast cancers revealed that high LC3II/TLR4 levels predicted an increased relapse rate and a poorer prognosis. Our findings demonstrate that autophagic CAFs play a critical role in promoting the progression of luminal breast cancer through an HMGB1–TLR4 axis, and that both autophagy in CAFs and TLR4 on breast cancer cells constitute potential therapeutic targets. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Cancer stem cells/cancer-initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer-associated fibroblasts (CAFs) are major components of the niche of breast cancer-initiating cells (BCICs), and their interactions may profoundly affect breast cancer progression. Autophagy has been considered to be a critical process for CIC maintenance, but whether it is involved in the cross-talk between CAFs and CICs to affect tumourigenesis and pathological significance has not been determined. In this study, we found that the presence of CAFs containing high levels of microtubule-associated protein 1 light chain 3 (LC3II), a marker of autophagosomes, was associated with more aggressive luminal human breast cancer. CAFs in human luminal breast cancer tissues with high autophagy activity enriched BCICs with increased tumourigenicity. Mechanistically, autophagic CAFs released high-mobility group box 1 (HMGB1), which activated its receptor, Toll-like receptor (TLR) 4, expressed by luminal breast cancer cells, to enhance their stemness and tumourigenicity. Furthermore, immunohistochemistry of 180 luminal breast cancers revealed that high LC3II/TLR4 levels predicted an increased relapse rate and a poorer prognosis. Our findings demonstrate that autophagic CAFs play a critical role in promoting the progression of luminal breast cancer through an HMGB1–TLR4 axis, and that both autophagy in CAFs and TLR4 on breast cancer cells constitute potential therapeutic targets. Cancer stem cells/cancer-initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer-associated fibroblasts (CAFs) are major components of the niche of breast cancer-initiating cells (BCICs), and their interactions may profoundly affect breast cancer progression. Autophagy has been considered to be a critical process for CIC maintenance, but whether it is involved in the cross-talk between CAFs and CICs to affect tumourigenesis and pathological significance has not been determined. In this study, we found that the presence of CAFs containing high levels of microtubule-associated protein 1 light chain 3 (LC3II), a marker of autophagosomes, was associated with more aggressive luminal human breast cancer. CAFs in human luminal breast cancer tissues with high autophagy activity enriched BCICs with increased tumourigenicity. Mechanistically, autophagic CAFs released high-mobility group box 1 (HMGB1), which activated its receptor, Toll-like receptor (TLR) 4, expressed by luminal breast cancer cells, to enhance their stemness and tumourigenicity. Furthermore, immunohistochemistry of 180 luminal breast cancers revealed that high LC3II/TLR4 levels predicted an increased relapse rate and a poorer prognosis. Our findings demonstrate that autophagic CAFs play a critical role in promoting the progression of luminal breast cancer through an HMGB1-TLR4 axis, and that both autophagy in CAFs and TLR4 on breast cancer cells constitute potential therapeutic targets. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Cancer stem cells/cancer-initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer-associated fibroblasts (CAFs) are major components of the niche of breast cancer-initiating cells (BCICs), and their interactions may profoundly affect breast cancer progression. Autophagy has been considered to be a critical process for CIC maintenance, but whether it is involved in the cross-talk between CAFs and CICs to affect tumourigenesis and pathological significance has not been determined. In this study, we found that the presence of CAFs containing high levels of microtubule-associated protein 1 light chain 3 (LC3II), a marker of autophagosomes, was associated with more aggressive luminal human breast cancer. CAFs in human luminal breast cancer tissues with high autophagy activity enriched BCICs with increased tumourigenicity. Mechanistically, autophagic CAFs released high-mobility group box 1 (HMGB1), which activated its receptor, Toll-like receptor (TLR) 4, expressed by luminal breast cancer cells, to enhance their stemness and tumourigenicity. Furthermore, immunohistochemistry of 180 luminal breast cancers revealed that high LC3II/TLR4 levels predicted an increased relapse rate and a poorer prognosis. Our findings demonstrate that autophagic CAFs play a critical role in promoting the progression of luminal breast cancer through an HMGB1-TLR4 axis, and that both autophagy in CAFs and TLR4 on breast cancer cells constitute potential therapeutic targets. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. |
Author | Fu, Wen‐Juan Zhao, Xi‐Long Bian, Xiu‐Wu Niu, Qin Lin, Yong Liang, Yan Tan, Jiao Wang, Ji Ming Zhang, Xia Tang, Zhuo Hu, Xu‐Gang Guo, De‐Yu Yan, Ze‐Xuan Lu, Lu Kung, Hsiang‐Fu Yang, Shuai Liu, Xue Yao, Xiao‐Hong Ping, Yi‐Fang Jiang, Jun |
AuthorAffiliation | 1 Institute of Pathology and Southwest Cancer Centre, Southwest Hospital, Third Military Medical University, Chongqing, PR China 2 Breast Disease Centre, Southwest Hospital, Third Military Medical University, Chongqing, PR China 3 Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA |
AuthorAffiliation_xml | – name: 2 Breast Disease Centre, Southwest Hospital, Third Military Medical University, Chongqing, PR China – name: 3 Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA – name: 1 Institute of Pathology and Southwest Cancer Centre, Southwest Hospital, Third Military Medical University, Chongqing, PR China |
Author_xml | – sequence: 1 givenname: Xi‐Long surname: Zhao fullname: Zhao, Xi‐Long organization: Southwest Hospital, Third Military Medical University – sequence: 2 givenname: Yong surname: Lin fullname: Lin, Yong organization: Southwest Hospital, Third Military Medical University – sequence: 3 givenname: Jun surname: Jiang fullname: Jiang, Jun organization: Southwest Hospital, Third Military Medical University – sequence: 4 givenname: Zhuo surname: Tang fullname: Tang, Zhuo organization: Southwest Hospital, Third Military Medical University – sequence: 5 givenname: Shuai surname: Yang fullname: Yang, Shuai organization: Southwest Hospital, Third Military Medical University – sequence: 6 givenname: Lu surname: Lu fullname: Lu, Lu organization: Southwest Hospital, Third Military Medical University – sequence: 7 givenname: Yan surname: Liang fullname: Liang, Yan organization: Southwest Hospital, Third Military Medical University – sequence: 8 givenname: Xue surname: Liu fullname: Liu, Xue organization: Southwest Hospital, Third Military Medical University – sequence: 9 givenname: Jiao surname: Tan fullname: Tan, Jiao organization: Southwest Hospital, Third Military Medical University – sequence: 10 givenname: Xu‐Gang surname: Hu fullname: Hu, Xu‐Gang organization: Southwest Hospital, Third Military Medical University – sequence: 11 givenname: Qin surname: Niu fullname: Niu, Qin organization: Southwest Hospital, Third Military Medical University – sequence: 12 givenname: Wen‐Juan surname: Fu fullname: Fu, Wen‐Juan organization: Southwest Hospital, Third Military Medical University – sequence: 13 givenname: Ze‐Xuan surname: Yan fullname: Yan, Ze‐Xuan organization: Southwest Hospital, Third Military Medical University – sequence: 14 givenname: De‐Yu surname: Guo fullname: Guo, De‐Yu organization: Southwest Hospital, Third Military Medical University – sequence: 15 givenname: Yi‐Fang surname: Ping fullname: Ping, Yi‐Fang organization: Southwest Hospital, Third Military Medical University – sequence: 16 givenname: Ji Ming surname: Wang fullname: Wang, Ji Ming organization: National Cancer Institute at Frederick – sequence: 17 givenname: Xia surname: Zhang fullname: Zhang, Xia organization: Southwest Hospital, Third Military Medical University – sequence: 18 givenname: Hsiang‐Fu surname: Kung fullname: Kung, Hsiang‐Fu email: hfkung@163.com organization: Southwest Hospital, Third Military Medical University – sequence: 19 givenname: Xiu‐Wu orcidid: 0000-0003-4383-0197 surname: Bian fullname: Bian, Xiu‐Wu email: bianxiuwu@263.net organization: Southwest Hospital, Third Military Medical University – sequence: 20 givenname: Xiao‐Hong surname: Yao fullname: Yao, Xiao‐Hong email: yxh15@hotmail.com organization: Southwest Hospital, Third Military Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28802057$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ksFuFSEUhompsbfVhS9gSNzoYlpghgtsTJrGek2a6KKuCcMwd2gYGIGp3p1Ll31Gn0TGXhttogvC4nzn5z-H_wgc-OANAM8xOsEIkdNJ5eGkEZQ_AiuMxLoSXKwPwKrUSFU3mB2Co5SuEUJCUPoEHBLOEUGUrcD3jd0OP77djqG1zuYd3MYwT7ANXyGG0Tijkulgu4NqzmEa1NZqqJXXJpYmlVLQVuVC9LaNoXUq5QRHZX0uJ8E8GJiyGb1JCYYeunm0XjnYxqKb90JQG-fSU_C4Vy6ZZ_v7GHy6eHt1vqkuP7x7f352WWmKBK96wupOa4101_e1QOuG18gIwjBmzAjBu5p3jOKWUkMoJUr1uqGUUy6I6PW6PgZv7nSnuR1Np43PUTk5RTuquJNBWfl3xdtBbsON5JjhRrAi8GovEMPn2aQsR5uWEZQ3YU4SC8IpLm-igr58gF6HOZYFLFRhECsOC_XiT0f3Vn5_UgFe3wE6hpSi6e8RjOQSALkEQC4BKOzpA1bbrLINyzDW_a_ji3Vm929p-fHsavOr4yfvI8b2 |
CitedBy_id | crossref_primary_10_1016_j_ebiom_2018_12_016 crossref_primary_10_1002_jcp_31278 crossref_primary_10_1016_j_bbadis_2022_166484 crossref_primary_10_1007_s10555_018_9768_3 crossref_primary_10_3390_cancers12123863 crossref_primary_10_1007_s00280_020_04222_w crossref_primary_10_1002_jcb_29473 crossref_primary_10_3390_cancers10110406 crossref_primary_10_1038_s41571_018_0007_1 crossref_primary_10_1002_mco2_549 crossref_primary_10_3389_fcell_2021_775462 crossref_primary_10_1002_kjm2_12299 crossref_primary_10_1016_j_senol_2021_08_003 crossref_primary_10_1016_j_semcancer_2018_08_002 crossref_primary_10_1038_s41575_020_0326_4 crossref_primary_10_3389_fonc_2020_01533 crossref_primary_10_3390_cancers13194756 crossref_primary_10_1002_cam4_2939 crossref_primary_10_1002_mco2_342 crossref_primary_10_1016_j_bbcan_2024_189105 crossref_primary_10_1186_s12964_020_00598_7 crossref_primary_10_1016_j_bbcan_2020_188416 crossref_primary_10_3390_ijms20010085 crossref_primary_10_1186_s13045_021_01087_1 crossref_primary_10_1186_s12935_022_02599_7 crossref_primary_10_18632_oncotarget_22161 crossref_primary_10_1016_j_biopha_2023_115425 crossref_primary_10_3389_fonc_2019_00820 crossref_primary_10_1016_j_bbcan_2023_189012 crossref_primary_10_1002_jcp_30419 crossref_primary_10_1002_jev2_70055 crossref_primary_10_1080_15548627_2019_1569947 crossref_primary_10_1177_1010428318756203 crossref_primary_10_1007_s13402_021_00634_9 crossref_primary_10_1016_j_soc_2019_02_010 crossref_primary_10_1038_s41419_018_0458_4 crossref_primary_10_3390_ijms222111636 crossref_primary_10_3892_br_2017_1034 crossref_primary_10_1038_s41598_020_75541_4 crossref_primary_10_1016_j_gendis_2023_05_024 crossref_primary_10_3390_diagnostics13121999 crossref_primary_10_1111_jcmm_13676 crossref_primary_10_1016_j_biopha_2023_114762 crossref_primary_10_1186_s13046_022_02291_8 crossref_primary_10_3390_cancers14010020 crossref_primary_10_1002_path_5189 crossref_primary_10_1016_j_rvsc_2024_105438 crossref_primary_10_1080_27694127_2024_2358648 crossref_primary_10_3389_fonc_2019_01104 crossref_primary_10_1016_j_canlet_2020_06_015 crossref_primary_10_1080_15548627_2019_1596479 crossref_primary_10_3389_or_2024_1507942 crossref_primary_10_3390_ijms21114158 crossref_primary_10_3390_ijms232012469 crossref_primary_10_3389_fphar_2018_00878 crossref_primary_10_3389_fcell_2021_727640 crossref_primary_10_1016_j_semcancer_2019_08_026 crossref_primary_10_3389_fonc_2024_1384109 crossref_primary_10_1038_s41419_019_1956_8 crossref_primary_10_3389_fonc_2020_606436 crossref_primary_10_3390_cancers12102896 crossref_primary_10_1038_s41392_021_00641_0 crossref_primary_10_3390_ijms21010254 crossref_primary_10_1039_C8TB03165G crossref_primary_10_1186_s12964_020_00619_5 crossref_primary_10_1007_s12282_018_00935_2 crossref_primary_10_1038_s41598_018_21416_8 crossref_primary_10_1038_s41388_019_0765_y crossref_primary_10_1002_slct_201800629 crossref_primary_10_1016_j_intimp_2024_113068 crossref_primary_10_3389_fcell_2021_620883 crossref_primary_10_1021_acsami_0c18545 crossref_primary_10_1038_s41556_018_0042_2 crossref_primary_10_1016_j_pharmthera_2019_04_004 crossref_primary_10_1042_EBC20170025 crossref_primary_10_1016_j_biopha_2022_113757 crossref_primary_10_1080_15384047_2019_1591122 crossref_primary_10_1186_s13046_019_1172_5 crossref_primary_10_1210_endrev_bnad005 crossref_primary_10_1016_j_isci_2022_104872 crossref_primary_10_1155_2021_8840066 crossref_primary_10_1038_s41419_021_04150_4 crossref_primary_10_1038_s43018_022_00426_6 crossref_primary_10_1186_s12943_022_01682_x |
Cites_doi | 10.1016/j.devcel.2010.05.012 10.1371/journal.pmed.1000010 10.4161/cc.20718 10.1002/path.2694 10.1158/0008-5472.CAN-11-3567 10.4161/15548627.2014.981788 10.1016/j.cell.2008.03.027 10.1186/bcr2231 10.1038/onc.2012.252 10.6026/97320630081147 10.1158/0008-5472.CAN-13-2563 10.1038/ncomms4472 10.1083/jcb.200911078 10.4161/auto.23997 10.1038/nrc3262 10.1097/CJI.0b013e31804efc76 10.1016/j.chembiol.2007.03.007 10.1016/j.stem.2007.08.014 10.1038/onc.2013.527 10.1126/stke.2002.151.pe39 10.1158/0008-5472.CAN-08-2741 10.1158/0008-5472.CAN-13-3536 10.1038/nrc3240 10.1016/j.neuint.2014.05.007 10.1111/j.1349-7006.2011.02183.x 10.1038/nature10694 10.1016/j.tcb.2012.04.008 10.1101/gad.1061803 10.1124/jpet.111.182592 10.1038/ni1457 10.1038/nrc2618 10.1093/emboj/20.16.4337 10.1038/onc.2012.111 10.1242/jcs.103630 10.1097/01.shk.0000225404.51320.82 10.1016/j.ajpath.2011.05.059 10.1126/science.1234740 10.1016/j.coi.2008.04.012 10.1016/S1470-2045(11)70257-1 10.1073/pnas.191367098 10.1038/nrm2617 10.7150/jca.10890 10.1093/annonc/mdr304 10.1002/stem.1031 10.1111/j.1600-065X.2007.00573.x 10.1002/jcp.24347 10.1124/mol.110.068064 10.1016/j.stem.2015.02.015 10.1038/35102167 |
ContentType | Journal Article |
Copyright | Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright © 2017 Pathological Society of Great Britain and Ireland |
Copyright_xml | – notice: Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. – notice: Copyright © 2017 Pathological Society of Great Britain and Ireland |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7T5 7TK 7TM 7TO 8FD FR3 H94 K9. P64 RC3 7X8 5PM |
DOI | 10.1002/path.4958 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Chemoreception Abstracts Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef Genetics Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1096-9896 |
EndPage | 389 |
ExternalDocumentID | PMC8171497 28802057 10_1002_path_4958 PATH4958 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United Kingdom--UK Ireland |
GeographicLocations_xml | – name: Ireland – name: United Kingdom--UK |
GrantInformation_xml | – fundername: National Natural Science Foundation of China funderid: 81372684; 81230062 – fundername: National Key Research and Development Programme of China Stem Cell and Translational Research funderid: 2016YFA0101203 – fundername: Key Laboratory of Tumour Immunopathology, Ministry of Education of China funderid: 2015jszl07 – fundername: Intramural NIH HHS grantid: Z01 BC010015 |
GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 123 1KJ 1L6 1OB 1OC 1ZS 29L 31~ 33P 3O- 3SF 3UE 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AI. AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA GSXLS H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M J5H JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M68 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OHT OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 SAMSI SUPJJ SV3 TEORI UB1 V2E VH1 W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 XPP XV2 YQI YQJ ZGI ZXP ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7QP 7QR 7T5 7TK 7TM 7TO 8FD FR3 H94 K9. P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c5098-f273dccc0cdff39064830e9271177e998d38d751b55e2552aafc455858929fc63 |
IEDL.DBID | DR2 |
ISSN | 0022-3417 1096-9896 |
IngestDate | Thu Aug 21 14:04:44 EDT 2025 Thu Jul 10 17:46:42 EDT 2025 Fri Jul 25 12:29:08 EDT 2025 Mon Jul 21 05:51:08 EDT 2025 Tue Jul 01 04:21:16 EDT 2025 Thu Apr 24 23:04:08 EDT 2025 Wed Jan 22 16:52:37 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | high-mobility group box 1 (HMGB1) breast cancer-initiating cell (BCIC) Toll-like receptor 4 (TLR4) autophagy cancer-associated fibroblast (CAF) |
Language | English |
License | Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5098-f273dccc0cdff39064830e9271177e998d38d751b55e2552aafc455858929fc63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 The authors contributed in the following way: X-LZ, YL: performed most of the experiments and wrote the manuscript; LL, SY: performed the lentivirus and adenovirus infection; XL, JJ, YL, TJ: collected the clinical specimens; X-GH, Z-XY, QN: prepared the reagents; W-JF: performed the western blotting; X-HY, Y-FP, D-YG: performed the immunohistochemical scoring; X-HY, X-WB: performed data analysis; J-MW, XZ: edited and revised the manuscript; X-HY, H-FK, X-WB: designed the study, revised the manuscript, and provided administrative management. Author contributions statement |
ORCID | 0000-0003-4383-0197 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/8171497 |
PMID | 28802057 |
PQID | 1951407552 |
PQPubID | 1006392 |
PageCount | 14 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8171497 proquest_miscellaneous_1928514550 proquest_journals_1951407552 pubmed_primary_28802057 crossref_primary_10_1002_path_4958 crossref_citationtrail_10_1002_path_4958 wiley_primary_10_1002_path_4958_PATH4958 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November 2017 |
PublicationDateYYYYMMDD | 2017-11-01 |
PublicationDate_xml | – month: 11 year: 2017 text: November 2017 |
PublicationDecade | 2010 |
PublicationPlace | Chichester, UK |
PublicationPlace_xml | – name: Chichester, UK – name: England – name: Bognor Regis |
PublicationTitle | The Journal of pathology |
PublicationTitleAlternate | J Pathol |
PublicationYear | 2017 |
Publisher | John Wiley & Sons, Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons, Ltd – name: Wiley Subscription Services, Inc |
References | 2015; 34 2010; 18 2007; 220 2010; 221 2003; 17 2007; 30 2012; 125 2012; 13 2012; 12 2012; 11 2013; 9 2012; 72 2002; 2002 2009; 11 2014; 5 2009; 10 2001 1986; 46 2006; 26 2007; 8 2011; 22 2008; 20 2010; 190 2011; 481 2007; 1 2014; 50 2012; 22 2014; 10 2001; 98 2009; 69 2011; 179 2015; 6 2011; 339 2015; 16 2013; 228 2000; 747—752 2011; 79 2013; 340 2012; 103 2007; 14 2012; 30 2001; 20 2013; 32 2009; 9 2009; 6 2014; 74 2008; 133 2012; 8 2014; 75 e_1_2_7_5_1 e_1_2_7_9_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_17_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_47_1 e_1_2_7_26_1 e_1_2_7_49_1 e_1_2_7_28_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_52_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_37_1 e_1_2_7_39_1 Perou CM (e_1_2_7_50_1) 2000; 747 e_1_2_7_6_1 Antoniou A (e_1_2_7_3_1) 2014; 50 e_1_2_7_4_1 e_1_2_7_8_1 e_1_2_7_18_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_14_1 e_1_2_7_42_1 Naito S (e_1_2_7_29_1) 1986; 46 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_48_1 e_1_2_7_27_1 e_1_2_7_51_1 e_1_2_7_30_1 e_1_2_7_53_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_38_1 |
References_xml | – volume: 72 start-page: 2768 year: 2012 end-page: 2779 article-title: CCL2 mediates cross‐talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells publication-title: Cancer Res – volume: 179 start-page: 1504 year: 2011 end-page: 1512 article-title: Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1 publication-title: Am J Pathol – volume: 8 start-page: 1147 year: 2012 end-page: 1153 article-title: Structural insight into the ligand–receptor interaction between glycyrrhetinic acid (GA) and the high‐mobility group protein B1 (HMGB1)–DNA complex publication-title: Bioinformation – volume: 12 start-page: 152 year: 2012 article-title: Enforced compliance publication-title: Nat Rev Cancer – volume: 14 start-page: 431 year: 2007 end-page: 441 article-title: Glycyrrhizin binds to high‐mobility group box 1 protein and inhibits its cytokine activities publication-title: Chem Biol – volume: 74 start-page: 2487 year: 2014 end-page: 2498 article-title: Curcumin promotes autophagic survival of a subset of colon cancer stem cells, which are ablated by DCLK1‐siRNA publication-title: Cancer Res – volume: 1 start-page: 555 year: 2007 end-page: 567 article-title: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome publication-title: Cell Stem Cell – volume: 6 start-page: 1331 year: 2015 end-page: 1336 article-title: Low dose, low cost estradiol pellets can support MCF‐7 tumour growth in nude mice without bladder symptoms publication-title: J Cancer – volume: 32 start-page: 699 year: 2013 end-page: 712 article-title: The autophagy‐associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells publication-title: Oncogene – volume: 22 start-page: 397 year: 2012 end-page: 406 article-title: Autophagy intersections with conventional and unconventional secretion in tissue development, remodeling and inflammation publication-title: Trends Cell Biol – volume: 228 start-page: 1651 year: 2013 end-page: 1657 article-title: Carcinoma‐associated fibroblasts: non‐neoplastic tumour‐promoting mesenchymal cells publication-title: J Cell Physiol – volume: 340 start-page: 559 year: 2013 end-page: 561 article-title: Cell biology. Unconventional secretion, unconventional solutions publication-title: Science – volume: 16 start-page: 225 year: 2015 end-page: 238 article-title: The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? publication-title: Cell Stem Cell – volume: 50 start-page: 3743 year: 2014 end-page: 3748 article-title: Cancer stem cells, a fuzzy evolving concept: a cell population or a cell property? publication-title: Cell Cycle – volume: 26 start-page: 174 year: 2006 end-page: 179 article-title: HMGB1 signals through toll‐like receptor (TLR) 4 and TLR2 publication-title: Shock – volume: 34 start-page: 27 year: 2015 end-page: 38 article-title: TGF‐beta receptor type‐2 expression in cancer‐associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre‐menopausal breast cancer publication-title: Oncogene – volume: 10 start-page: 148 year: 2009 end-page: 155 article-title: Mechanisms of regulated unconventional protein secretion publication-title: Nat Rev Mol Cell Biol – volume: 11 start-page: 2285 year: 2012 end-page: 2302 article-title: Autophagy and senescence in cancer‐associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production publication-title: Cell Cycle – volume: 98 start-page: 10869 year: 2001 end-page: 10874 article-title: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications publication-title: Proc Natl Acad Sci U S A – volume: 79 start-page: 34 year: 2011 end-page: 41 article-title: TAK‐242 (resatorvid), a small‐molecule inhibitor of Toll‐like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules publication-title: Mol Pharmacol – volume: 5 start-page: 3472 year: 2014 article-title: Cancer‐associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling publication-title: Nat Commun – volume: 220 start-page: 47 year: 2007 end-page: 59 article-title: The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy publication-title: Immunol Rev – volume: 8 start-page: 487 year: 2007 end-page: 496 article-title: Toll‐like receptor 9‐dependent activation by DNA‐containing immune complexes is mediated by HMGB1 and RAGE publication-title: Nat Immunol – volume: 103 start-page: 400 year: 2012 end-page: 407 article-title: Interactions between tumor cells and microenvironment in breast cancer: a new opportunity for targeted therapy publication-title: Cancer Sci – volume: 9 start-page: 239 year: 2009 end-page: 252 article-title: Microenvironmental regulation of metastasis publication-title: Nat Rev Cancer – volume: 17 start-page: 1253 year: 2003 end-page: 1270 article-title: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells publication-title: Genes Dev – volume: 20 start-page: 518 year: 2008 end-page: 523 article-title: HMGB1: a two‐headed signal regulating tumor progression and immunity publication-title: Curr Opin Immunol – volume: 46 start-page: 4109 year: 1986 end-page: 4115 article-title: Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice publication-title: Cancer Res – volume: 20 start-page: 4337 year: 2001 end-page: 4340 article-title: New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal publication-title: EMBO J – volume: 18 start-page: 884 year: 2010 end-page: 901 article-title: Tumors as organs: complex tissues that interface with the entire organism publication-title: Dev Cell – volume: 2002 start-page: pe39 year: 2002 article-title: At the crossroads of necrosis and apoptosis: signaling to multiple cellular targets by HMGB1 publication-title: Sci STKE – volume: 11 start-page: R12 year: 2009 article-title: Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells publication-title: Breast Cancer Res – volume: 133 start-page: 704 year: 2008 end-page: 715 article-title: The epithelial–mesenchymal transition generates cells with properties of stem cells publication-title: Cell – start-page: 105 year: 2001 end-page: 111 article-title: Stem cells, cancer, and cancer stem cells publication-title: Nature – volume: 339 start-page: 93 year: 2011 end-page: 98 article-title: Glycyrrhizin prevents liver injury by inhibition of high‐mobility group box 1 production by Kupffer cells after ischemia–reperfusion in rats publication-title: J Pharmacol Exp Ther – volume: 12 start-page: 401 year: 2012 end-page: 410 article-title: Deconvoluting the context‐dependent role for autophagy in cancer publication-title: Nat Rev Cancer – volume: 481 start-page: 85 year: 2011 end-page: 89 article-title: Interactions between cancer stem cells and their niche govern metastatic colonization publication-title: Nature – volume: 69 start-page: 1302 year: 2009 end-page: 1313 article-title: Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature publication-title: Cancer Res – volume: 32 start-page: 2261 year: 2013 end-page: 2272 article-title: Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem‐like/progenitor cells publication-title: Oncogene – volume: 9 start-page: 714 year: 2013 end-page: 729 article-title: Inhibition of the autophagic flux by salinomycin in breast cancer stem‐like/progenitor cells interferes with their maintenance publication-title: Autophagy – volume: 190 start-page: 881 year: 2010 end-page: 892 article-title: Endogenous HMGB1 regulates autophagy publication-title: J Cell Biol – volume: 22 start-page: 1736 year: 2011 end-page: 1747 article-title: Strategies for subtypes – dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 publication-title: Ann Oncol – volume: 221 start-page: 117 year: 2010 end-page: 124 article-title: Autophagy: assays and artifacts publication-title: J Pathol – volume: 75 start-page: 32 year: 2014 end-page: 38 article-title: High‐mobility group box 1 up‐regulates aquaporin 4 expression via microglia–astrocyte interaction publication-title: Neurochem Int – volume: 125 start-page: 5251 year: 2012 end-page: 5255 article-title: Diversity in unconventional protein secretion publication-title: J Cell Sci – volume: 74 start-page: 5746 year: 2014 end-page: 5757 article-title: Metastatic consequences of immune escape from NK cell cytotoxicity by human breast cancer stem cells publication-title: Cancer Res – volume: 747—752 start-page: 406 year: 2000 article-title: Molecular portraits of human breast tumours publication-title: Nature – volume: 6 year: 2009 article-title: HMGB1 mediates endogenous TLR2 activation and brain tumor regression publication-title: PLoS Med – volume: 30 start-page: 596 year: 2007 end-page: 606 article-title: High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy publication-title: J Immunother – volume: 30 start-page: 363 year: 2012 end-page: 371 article-title: Colorectal cancer stem cells publication-title: Stem Cells – volume: 10 start-page: 2122 year: 2014 end-page: 2142 article-title: Inhibition of autophagy as a new means of improving chemotherapy efficiency in high‐LC3B triple‐negative breast cancers publication-title: Autophagy – volume: 13 start-page: e83 year: 2012 end-page: e89 article-title: The developing cancer stem‐cell model: clinical challenges and opportunities publication-title: Lancet Oncol – ident: e_1_2_7_2_1 doi: 10.1016/j.devcel.2010.05.012 – volume: 46 start-page: 4109 year: 1986 ident: e_1_2_7_29_1 article-title: Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice publication-title: Cancer Res – ident: e_1_2_7_44_1 doi: 10.1371/journal.pmed.1000010 – ident: e_1_2_7_23_1 doi: 10.4161/cc.20718 – ident: e_1_2_7_30_1 doi: 10.1002/path.2694 – ident: e_1_2_7_15_1 doi: 10.1158/0008-5472.CAN-11-3567 – ident: e_1_2_7_19_1 doi: 10.4161/15548627.2014.981788 – ident: e_1_2_7_26_1 doi: 10.1016/j.cell.2008.03.027 – ident: e_1_2_7_39_1 doi: 10.1186/bcr2231 – ident: e_1_2_7_16_1 doi: 10.1038/onc.2012.252 – ident: e_1_2_7_35_1 doi: 10.6026/97320630081147 – ident: e_1_2_7_27_1 doi: 10.1158/0008-5472.CAN-13-2563 – ident: e_1_2_7_14_1 doi: 10.1038/ncomms4472 – ident: e_1_2_7_42_1 doi: 10.1083/jcb.200911078 – ident: e_1_2_7_17_1 doi: 10.4161/auto.23997 – ident: e_1_2_7_37_1 doi: 10.1038/nrc3262 – ident: e_1_2_7_48_1 doi: 10.1097/CJI.0b013e31804efc76 – ident: e_1_2_7_33_1 doi: 10.1016/j.chembiol.2007.03.007 – ident: e_1_2_7_11_1 doi: 10.1016/j.stem.2007.08.014 – ident: e_1_2_7_12_1 doi: 10.1038/onc.2013.527 – ident: e_1_2_7_49_1 doi: 10.1126/stke.2002.151.pe39 – volume: 50 start-page: 3743 year: 2014 ident: e_1_2_7_3_1 article-title: Cancer stem cells, a fuzzy evolving concept: a cell population or a cell property? publication-title: Cell Cycle – ident: e_1_2_7_10_1 doi: 10.1158/0008-5472.CAN-08-2741 – ident: e_1_2_7_38_1 doi: 10.1158/0008-5472.CAN-13-3536 – ident: e_1_2_7_6_1 doi: 10.1038/nrc3240 – ident: e_1_2_7_32_1 doi: 10.1016/j.neuint.2014.05.007 – ident: e_1_2_7_7_1 doi: 10.1111/j.1349-7006.2011.02183.x – ident: e_1_2_7_9_1 doi: 10.1038/nature10694 – ident: e_1_2_7_20_1 doi: 10.1016/j.tcb.2012.04.008 – ident: e_1_2_7_25_1 doi: 10.1101/gad.1061803 – ident: e_1_2_7_34_1 doi: 10.1124/jpet.111.182592 – ident: e_1_2_7_46_1 doi: 10.1038/ni1457 – ident: e_1_2_7_4_1 doi: 10.1038/nrc2618 – ident: e_1_2_7_31_1 doi: 10.1093/emboj/20.16.4337 – ident: e_1_2_7_18_1 doi: 10.1038/onc.2012.111 – ident: e_1_2_7_41_1 doi: 10.1242/jcs.103630 – ident: e_1_2_7_45_1 doi: 10.1097/01.shk.0000225404.51320.82 – ident: e_1_2_7_28_1 doi: 10.1016/j.ajpath.2011.05.059 – ident: e_1_2_7_22_1 doi: 10.1126/science.1234740 – ident: e_1_2_7_47_1 doi: 10.1016/j.coi.2008.04.012 – ident: e_1_2_7_53_1 doi: 10.1016/S1470-2045(11)70257-1 – ident: e_1_2_7_51_1 doi: 10.1073/pnas.191367098 – ident: e_1_2_7_21_1 doi: 10.1038/nrm2617 – ident: e_1_2_7_40_1 doi: 10.7150/jca.10890 – ident: e_1_2_7_24_1 doi: 10.1093/annonc/mdr304 – ident: e_1_2_7_8_1 doi: 10.1002/stem.1031 – ident: e_1_2_7_43_1 doi: 10.1111/j.1600-065X.2007.00573.x – ident: e_1_2_7_13_1 doi: 10.1002/jcp.24347 – ident: e_1_2_7_36_1 doi: 10.1124/mol.110.068064 – volume: 747 start-page: 406 year: 2000 ident: e_1_2_7_50_1 article-title: Molecular portraits of human breast tumours publication-title: Nature – ident: e_1_2_7_52_1 doi: 10.1016/j.stem.2015.02.015 – ident: e_1_2_7_5_1 doi: 10.1038/35102167 |
SSID | ssj0009955 |
Score | 2.5298977 |
Snippet | Cancer stem cells/cancer‐initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis.... Cancer stem cells/cancer-initiating cells (CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis.... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 376 |
SubjectTerms | Aged Aged, 80 and over Autophagy Breast cancer breast cancer‐initiating cell (BCIC) Breast Neoplasms - metabolism Breast Neoplasms - pathology Cancer-Associated Fibroblasts - metabolism Cancer-Associated Fibroblasts - pathology cancer‐associated fibroblast (CAF) Cell Line, Tumor Cell Transformation, Neoplastic - metabolism Cell Transformation, Neoplastic - pathology Female Fibroblasts high‐mobility group box 1 (HMGB1) HMGB1 protein HMGB1 Protein - metabolism Humans Immunohistochemistry Metastases Microtubule-associated protein 1 Microtubule-Associated Proteins - metabolism Middle Aged Mobility Neoplasm Recurrence, Local - metabolism Neoplasm Recurrence, Local - pathology Neoplastic Stem Cells - metabolism Neoplastic Stem Cells - pathology Phagocytosis Phagosomes Stem cells TLR4 protein Toll-Like Receptor 4 - metabolism Toll-like receptors Toll‐like receptor 4 (TLR4) Tumor Microenvironment - physiology Tumorigenesis Tumors |
Title | High‐mobility group box 1 released by autophagic cancer‐associated fibroblasts maintains the stemness of luminal breast cancer cells |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpath.4958 https://www.ncbi.nlm.nih.gov/pubmed/28802057 https://www.proquest.com/docview/1951407552 https://www.proquest.com/docview/1928514550 https://pubmed.ncbi.nlm.nih.gov/PMC8171497 |
Volume | 243 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hDhUX-uCVdlsZxIFLlsSO8xCnVVW0qgRCCCQOSJHtxAK1m1QkK5Weeuyxv7G_hJm86EKRUG8rZbzreGfG39gz3wDsqtzzFG4bbojbnRtEGLMSjZSLEXNguTIqtHQOeXQcTs-DzxfyYgkO-lqYlh9iOHAjy2j8NRm40tX-PWkodewdI7ynQl_K1SJAdHpPHZUkUg5M4YEf9axCHt8fRi7uRY8A5uM8yb_xa7MBHb6Ey37qbd7Jl_G81mPz4wGr43--2ytY7YApm7Sa9BqW8uINvDjqrt7X4BdlhPz5-XtWNum0t6ypB2G6_M58Rp1XcDvMmL5lak5cBQo9KjOkUjc4SHVKgBIWJ1ZqxOx1xWbquqCjiYohDGVEKU2Ol5WWocukdl1MU8583X0Ro1uGah3ODz-dfZy6XRsH10hiK7WIkDJjjGcya0WCGCgWXp7wiO6Lcwz3MhFnkfS1lDkGOFwpawKJYUyM0M2aUGzAclEW-RYwIVWohRdkKhEoEqowxojKJr6wXiAC48Be_4empuM4p1YbX9OWnZmntLIprawDO4Pot5bY419Co14r0s62q9RHUIphMM7Uge3hMVolLYIq8nJOMhyhLFWMO7DZKtHwKxxdJkeY7EC0oF6DADF-Lz4prq8a5u-Y2tUnOHKv0Z6nJ56eTM6m9OHt80XfwQonzNIUWo5gub6Z5-8RcdX6Q2NadwLdLI4 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTxRBEK7gmggXHoo4CNIaD1xmmemenkfChahkBZYYsyRczKSnZzoSZcbszibAyaNHfyO_hKp54YokxNsmU73b01uPr7qrvwJ4qzLHURg2bB_Dne0FmLMSjZSNGbNnuNLKN7QPOTz2Byfewak8nYPd9i5MzQ_RbbiRZVT-mgycNqR3bllDqWVvH_F9-AgeU0dvYs5___mWPCqKpOy4wj03aHmFHL7TDZ2NRncg5t1KyT8RbBWC9pfgSzv5uvLkW39aJn199Rev4_--3TIsNtiU7dXKtAJzWf4Ungyb0_dn8IuKQq5__j4vqoraS1ZdCWFJccFcRs1XMCKmLLlkakp0BQqdKtOkVWMcpBo9QAmDMysShO3lhJ2rs5x2JyYMkSgjVmnyvawwDL0mdexiCZXNl80XMTpomKzCyf6H0buB3XRysLUkwlKDICnVWjs6NUZECINC4WQRD-jIOMOMLxVhGkg3kTLDHIcrZbQnMZMJEb0Z7Yvn0MuLPHsBTEjlJ8LxUhUJFPGVH2JSZSJXGMcTnrZgu_1HY93QnFO3je9xTdDMY1rZmFbWgjed6I-a2-NfQhutWsSNeU9iF3EpZsI4Uwted4_RMGkRVJ4VU5LhiGbp0rgFa7UWdb_C0WtyRMoWBDP61QkQ6ffsk_zsa0X-HVLH-ghHblfqc__E4097owF9WH-46BbMD0bDo_jo4_HhS1jgBGGqe5cb0CvH02wTAViZvKrs7AaYiDCq |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTxRBEK4gJsSLIj4YQW2NBy6zzPRjHvFExM0KQoiBhIPJpKdnOhJkhrCzCXDiyJHf6C-hal6woAnxtslU7_b01uOr7uqvAD7p3PM0hg03wHDnyhBzVqKRcjFjlpZrowNL-5Bb28FoT27sq_0Z-NzdhWn4IfoNN7KM2l-TgR9ndvWGNJQ69g4Q3keP4LEMvJj6Nqz_uOGOimOleqpw6YcdrZDHV_uh08HoHsK8Xyh5G8DWEWj4DH52c28KTw4HkyodmPM7tI7_-XLz8LRFpmytUaXnMJMXCzC31Z69v4BLKgn5c3F1VNb1tGesvhDC0vKU-Yxar2A8zFh6xvSEyAo0ulRmSKdOcJButQAlLE6sTBG0V2N2pA8K2psYM8ShjDilyfOy0jL0mdSvi6VUNF-1X8TomGH8EvaGX3e_jNy2j4NrFNGVWoRImTHGM5m1IkYQFAkvj3lIB8Y55nuZiLJQ-alSOWY4XGtrpMI8JkLsZk0gXsFsURb5IjChdJAKT2Y6FigS6CDClMrGvrCeFNI4sNL9oYlpSc6p18bvpKFn5gmtbEIr68DHXvS4Yfb4m9BypxVJa9zjxEdUinkwztSBD_1jNEtaBF3k5YRkOGJZujLuwOtGifpf4egzOeJkB8Ip9eoFiPJ7-klx8Kum_o6oX32MI1dq7fn3xJOdtd0RfXjzcNH3MLezPky-f9veXIInnPBLfelyGWark0n-FtFXlb6rrewa9ZkvWQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High-mobility+group+box+1+released+by+autophagic+cancer-associated+fibroblasts+maintains+the+stemness+of+luminal+breast+cancer+cells&rft.jtitle=The+Journal+of+pathology&rft.au=Zhao%2C+Xi-Long&rft.au=Lin%2C+Yong&rft.au=Jiang%2C+Jun&rft.au=Tang%2C+Zhuo&rft.date=2017-11-01&rft.issn=0022-3417&rft.eissn=1096-9896&rft.volume=243&rft.issue=3&rft.spage=376&rft.epage=389&rft_id=info:doi/10.1002%2Fpath.4958&rft_id=info%3Apmid%2F28802057&rft.externalDocID=PMC8171497 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3417&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3417&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3417&client=summon |